InvestorsHub Logo
Followers 39
Posts 1345
Boards Moderated 2
Alias Born 03/03/2013

Re: None

Friday, 05/16/2014 12:03:32 PM

Friday, May 16, 2014 12:03:32 PM

Post# of 1431
About new merger:

This is their website:

PlasmaGenix is a biologics company located in Inglewood, California. Our three lead products, PlasmaNeu, PlasmaGen and PlasmaPro, have been used for over a decade to treat chronic non-healing wounds and preventing amputations in high risk populations, and? peripheral neuropathy associated with HIV and Diabetes.

http://www.plasmagenix.com/

Bio from Business week:

PlasmaGenix, Inc. develops and commercializes regenerative therapeutics derived from the patients own blood. The company offers PlasmaPro, a mixture of platelet rich and platelet poor plasma combined with a platelet aggregator to amplify the release of various growth factors; PlasmaNeu is platelet derived neurogenic growth factors that act on regenerating peripheral nerves; and PlasmaGen, a platelet-rich fibrin matrix combined with a collagen microscaffold that is applied topically to a chronic non-healing wound. Its products are used to treat chronic non-healing wounds, prevent amputations in high risk populations, and peripheral neuropathy associated with HIV and diabetes. The company is based in Inglewood, California. As of February 19, 2014, PlasmaGenix, Inc. operates as a subsidiary of Earth Dragon Resources Inc.

http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=257160612

***I know no Facts. I speak only Opinions.***

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.